Atrial septal defect migraine: Difference between revisions
No edit summary |
No edit summary |
||
| Line 21: | Line 21: | ||
*Anti-convulsants: [[valproate]], [[gabapentin]], [[topiramate]] | *Anti-convulsants: [[valproate]], [[gabapentin]], [[topiramate]] | ||
*Other [[prophylaxis]]: botuliunum toxin, [[butterbur]], [[coenzyme Q10]], [[feverfew]], [[magnesium]], [[methysergide]], [[opioids]], [[pizotifen]], [[riboflavin]] | *Other [[prophylaxis]]: botuliunum toxin, [[butterbur]], [[coenzyme Q10]], [[feverfew]], [[magnesium]], [[methysergide]], [[opioids]], [[pizotifen]], [[riboflavin]] | ||
==References== | |||
{{reflist|2}} | |||
==See also== | ==See also== | ||
| Line 29: | Line 32: | ||
[[Category:Congenital heart disease]] | [[Category:Congenital heart disease]] | ||
[[Category:Pediatrics]] | [[Category:Pediatrics]] | ||
[[Category:Embryology]] | |||
[[Category:Disease state]] | [[Category:Disease state]] | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
[[Category:Overview complete]] | |||
[[ | [[Category:Up-To-Date]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 05:11, 10 September 2011
|
Atrial Septal Defect Microchapters | |
|
Treatment | |
|---|---|
|
Surgery | |
|
| |
|
Special Scenarios | |
|
Case Studies | |
|
Atrial septal defect migraine On the Web | |
|
American Roentgen Ray Society Images of Atrial septal defect migraine | |
|
Risk calculators and risk factors for Atrial septal defect migraine | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]; Cafer Zorkun, M.D., Ph.D. [3] Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [4]
Overview
Research suggests that some atrial septal defect patients may develop a comorbidity complex involving migraines. While there is no direct link to migraines and atrial septal defects, research has noted that treatment of defects such as patent foramen ovale can reduce the severity of migraine symptoms. Additional research has indicated a number of effective medical therapies that have successfully influenced reduction in migraine instance and overall morbidity of atrial septal defect symptoms.
Migraine
Some recent research has suggested that a proportion of cases of migraine may be caused by patent foramen ovale. While the exact mechanism remains unclear, closure of a PFO can reduce symptoms in certain cases.[1][2] This remains controversial. 20% of the general population have a PFO, which for the most part, is asymptomatic. 20% of the female population have migraines. And, the placebo effect in migraine typically averages around 40%. The high frequency of these facts makes statistically significant relationships between PFO and migraine difficult (i.e., the relationship may just be chance or coincidence).
Medical therapy for migraines
Although there is no direct evidence to link migraines and atrial septal defects, some research has noted that treatment of patent foramen ovale can reduce the severity of migraine symptoms.[3][4]
Effective pharmacologic therapies for migraine prevention include:
- Anti-hypertensives: beta blockers (propranolol, timolol, metoprolol, nadolol, and atenolol), calcium channel blockers (verapamil, nifedipine, and nimodipine), and angiotensin converting enzyme inhibitors/angiotensin II receptor blockers (lisinopril, candesartan)
- Anti-depressants: amitriptyline, venlafaxine, nortriptyline, doxepin, protriptyline
- Anti-convulsants: valproate, gabapentin, topiramate
- Other prophylaxis: botuliunum toxin, butterbur, coenzyme Q10, feverfew, magnesium, methysergide, opioids, pizotifen, riboflavin
References
- ↑ Adams H (2004). "Patent foramen ovale: paradoxical embolism and paradoxical data". Mayo Clin Proc. 79 (1): 15–20. PMID 14708944.
- ↑ Azarbal B, Tobis J, Suh W, Chan V, Dao C, Gaster R (2005). "Association of interatrial shunts and migraine headaches: impact of transcatheter closure". J Am Coll Cardiol. 45 (4): 489–92. PMID 15708691.
- ↑ Azarbal B, Tobis J, Suh W, Chan V, Dao C, Gaster R (2005). "Association of interatrial shunts and migraine headaches: impact of transcatheter closure". J Am Coll Cardiol. 45 (4): 489–92. PMID 15708691.
- ↑ Adams H (2004). "Patent foramen ovale: paradoxical embolism and paradoxical data". Mayo Clin Proc. 79 (1): 15–20. PMID 14708944.